Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2016 16:57 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Reports Fourth Quarter and Fiscal 2016 Year End Results

RANCHO CORDOVA, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today reported fourth quarter and full...
September 19, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Granted Two Patents for Rapid Infusion of Autologous Bone Marrow Derived Stem Cells

RANCHO CORDOVA, Calif., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the United States...
September 16, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Report Fiscal Fourth Quarter and Full Year 2016 Financial Results and Provide Business Update

RANCHO CORDOVA, Calif., Sept. 16, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it will report...
September 08, 2016 13:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the 18th Annual Rodman & Renshaw® Global Investment Conference

RANCHO CORDOVA, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Michael Bruch,...
August 24, 2016 21:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Conversion of $12.5 Million in Senior Secured Debt to Equity

RANCHO CORDOVA, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has...
August 04, 2016 09:07 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Pricing of $2.5 Million Registered Direct Offering

RANCHO CORDOVA, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it has entered into...
August 03, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Promising Results From 40-Month Follow-Up of Patients Enrolled in Critical Limb Ischemia Feasibility Study

RANCHO CORDOVA, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced 40-month follow-up...
August 02, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Publication of Results on Use of Its Technology for Treatment of Non-Union Fracture

RANCHO CORDOVA, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that data for its...
August 01, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Provides Update on FDA Review of Investigational Device Exemption Supplement for SurgWerks™ CLI Pivotal Trial

FDA Approves Commencement of Phase III Pivotal Trial as Amended Requires Additional Validation of TcPO2 as a Surrogate to Support Subsequent PMA Approval RANCHO CORDOVA, Calif., Aug. 01,...
June 20, 2016 06:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Appoints Mark Bagnall to Its Board of Directors

RANCHO CORDOVA, Calif., June 20, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Mr. Mark Bagnall has...